BS

Bollepalli Seetha Ravamma

Director Director DIN 05354469
DIN 05354469 First appointment Mar 2012 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since Mar 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Bollepalli Seetha Ravamma

Data last updated:

Bollepalli Seetha Ravamma has 14 years in corporate governance. Formerly with 1 company, such as Bridge Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 05354469
Primary Designation Director
First Appointment 31 Mar 2012
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Mar 20122003₹19.4 Lakh (FY 2021)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bridge Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Bollepalli Seetha Ravamma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bollepalli Seetha Ravamma

Bollepalli Seetha Ravamma has 14 years in corporate governance. Formerly with 1 company, such as Bridge Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Bollepalli Seetha Ravamma has expertise in General Business.

Bollepalli Seetha Ravamma has 14 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available